Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['bladder', 'urothelial', 'erdafitinib']
erdafitinib extends survival in post-immunotherapy, fgfr-altered urothelial cancer #asco23 #urology #urologist #bladdercancer #urothelialcarcinoma
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.